Bristol-Myers Squibb Company (BMY) is expected to report earnings on Thursday, October 29, 2026, after the close. Estimated release time 07:08 ET. Consensus EPS estimate is $1.68.
| Report date | Quarter | EPS est. | EPS actual | Surprise | Revenue |
|---|---|---|---|---|---|
| 2026-07-30 | FY2026 Q2 | $1.60 | $2.04 | +27.5% | $12.97B |
| 2026-04-30 | FY2026 Q1 | $1.42 | $1.58 | +11.3% | $11.49B |
| 2026-02-11 | FY2025 Q4 | $1.23 | $1.26 | +2.4% | $12.50B |
| 2025-10-30 | FY2025 Q3 | $1.52 | $1.63 | +7.2% | $12.22B |
| 2025-07-31 | FY2025 Q2 | $1.09 | $1.46 | +33.9% | $12.27B |
| 2025-04-24 | FY2025 Q1 | $1.49 | $1.80 | +20.8% | $11.20B |
| 2025-02-12 | FY2024 Q4 | $1.47 | $1.67 | +13.6% | $12.34B |
| 2024-10-31 | FY2024 Q3 | $1.49 | $1.80 | +20.8% | $11.89B |
BMY has beaten consensus EPS in 8 of its last 8 reported quarters.
See BMY on the live calendar →